Growing Adoption of 25-Hydroxy D Vitamin Test as a Less-invasive Option

Vitamin D deficiency is a common problem faced by many people all around the world, particularly older adults. Since vitamin D plays an important role in the development and calcification of the bones, a lot of individuals are seeking easy and safer ways of testing their vitamin D levels.

Stakeholders in the vitamin D testing landscape are evaluating the use of HPLC (High Performance Liquid Chromatography) to assess the analytical performance of the 25-hydroxy D vitamin test in human serum. This has been validated with the help of the electrochemiluminescence (ECL) method. Results showed that, HPLC assay indicates exceptional linearity with admissible accuracy to measure vitamin D using the ECL method. Also, the relatively short analysis time makes it a lucrative alternative for stakeholders in the vitamin D testing landscape, to facilitate healthcare providers with a preferred technique in routine diagnostic laboratory practices.

25-hydroxy vitamin d measurement also serves as a less-invasive test in the vitamin D testing landscape. A recent study conducted by Trinity College, Dublin, and St. James Hospital, suggested the feasibility of the 25-hydroxy vitamin d test to measure the levels of vitamin D using only hair samples. Ongoing research & development in the vitamin D testing landscape warrant further validation of the 25-hydroxy vitamin d test to yield valuable information related to vitamin D physiology.

vitamin d testing market infographic

To know the scope of our report Get a Sample on Vitamin D Testing Market 

ELISA Technique Serves as Lucrative Alternative for Early Detection of VDD

Since the Enzyme Linked Immunosorbent Assay (ELISA) technique accounts for one of the largest market shares of ~ 28% in the vitamin D testing landscape, stakeholders are collaborating with research professionals to identify the association of serum 25-hydroxy vitamin D with leptin and visceral fat in type 2 diabetes patients suffering from osteoporosis. These research studies are being validated using the ELISA and ECL methods. As a result, the data establishes a strong association and reflected decreased 25-hydroxy vitamin D levels and increased leptin fat in type 2 diabetes patients suffering from osteoporosis.

Likewise, vitamin D deficiency (VDD) is a common health issue in women during the early stage of pregnancy. As such, various clinical trials using ELISA have been carried out to measure the concentrations of 25-hydroxy vitamin D. It has been proven that, women usually suffer from vitamin D deficiency during early pregnancy. Thus, stakeholders in the vitamin D testing landscape need to innovate and develop preventive techniques and ways of early detection of VDD during early pregnancy.

Get a glimpse of the in-depth analysis through our Report Brochure

Need to Harmonize Human Serum Treatment in Tandem with Vitamin D Antibodies

The accurate and precise measurement of 25-hydroxy vitamin D is one of the primary challenges that is associated with healthcare providers in the vitamin D testing landscape. As such, healthcare providers face limitations as vitamin D analytes are tightly bound to their serum transporter.

For example, liquid chromatography in relation to the mass spectrometry (LC-MS) technique offers an excellent level of accuracy and sensitivity in the vitamin D testing landscape. However, not all LC-MS results are deemed as equal by healthcare providers in hospitals and diagnostic laboratories. Likewise, radioimmunoassays (RIA) offer high specificity of 25-hydroxy vitamin D concentrations. Though, the reliability of the RIA technique is dependent on the quality of monoclonal antibody that is introduced during the test. Thus, harmonization of human serum treatment methods and narrowing the scope of vitamin D antibodies are critical steps that stakeholders and healthcare providers need to take in order to bring vitamin D testing methods to a universal agreement.

vitamin d testing market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

Analysts of the vitamin D testing landscape have a positive outlook for market growth during the forecast period of 2019-2027. The vitamin D testing market is estimated to rise at a CAGR of ~6%. North America and Europe dominate the global market share in the vitamin D testing landscape, whereas, Asia Pacific has high growth potential in the coming years. One of the latest techniques in the vitamin D testing landscape is chemiluminescence immunoassays (CLIA). However, stakeholders and healthcare providers need to innovate on the interference problem that occurs in the LC-MS technique. Stakeholders must also address the cross-reaction limitation seen in vitamin D assays.

Vitamin D Deficiency and Testing

Vitamin D can be defined as a steroid vitamin, which is engaged in promoting metabolism and intestinal absorption of phosphorus and calcium. Vitamin D is produced in the skin, and is obtained through a diet. Under normal conditions of sun exposure, additional vitamin D supplements are not necessary. In order to determine if the vitamin D level in the serum plasma sample of an individual is low, vitamin D testing is performed, which measures the vitamin D levels in the body, accurately.

Significant Partnerships to Contribute to Market Growth

  • The global vitamin D testing market was valued at ~US$ 519 Mn in 2018, and is projected to reach ~US$ 877 Mn by 2027, expanding at a CAGR of ~6% from 2019 to 2027.
  • Significant distribution partnerships among market players for the distribution of their vitamin D test kits, globally, fuel the growth of the vitamin D testing market. For instance, NanoSpeed Diagnostics entered into an exclusive distribution partnership with Unilab Laboratories in 2015 for the distribution of Test4D, a 25-OH vitamin D deficiency test kit, in the Philippines. This enabled NanoSpeed to expand its presence in countries in Asia.
  • In 2016, Sekisui Diagnostics and Qualigen entered into a strategic partnership for the distribution of the FastPack IP System, which includes vitamin D, testosterone, TSH, free T4, PSA, and hCG.

Vitamin D Deficiency Epidemic

  • Vitamin D deficiency is an ignored epidemic that is highly prevalent, globally. However, no international organization or governmental body has declared a health emergency about the need of maintaining the required vitamin D levels in the blood. It is estimated that over 1 billion people around the world have vitamin D deficiency or insufficiency. Vitamin D deficiency primarily affects pregnant women, infants, neonates, children, and the elderly.
  • Vitamin D deficiency is known to be common in Northern Europe, especially in women with pigmented skin. The deficiency is reported to be three times more common in the winter months as compared to other months in the U.K.
  • Rise in the prevalence of vitamin D deficiency and the surging focus on its importance contribute to the increase in screening for vitamin D serum levels, which, in turn, boosts the growth of the global vitamin D testing market.

North America to Capture Leading Market Share

  • The report offers detailed segmentation of the global vitamin D testing market based on test, technique, patient type, indication, end-user, and region. In terms of test type, the global vitamin D testing market has been classified into 25-hydroxy D vitamin and 1,25-dihydroxy D vitamin.
  • Based on technique, the global vitamin D testing market has been categorized into radioimmunoassay, ELISA, HPLC, LC-MS, and others. In terms of patient type, the global vitamin D testing market has been bifurcated into adult and pediatric.
  • Based on indication, the global vitamin D testing market has been split into osteoporosis, rickets, thyroid disorders, malabsorption, vitamin D deficiency, and others. In terms of end-user, the global vitamin D testing market has been divided into hospitals, diagnostic laboratories, home care, point-of-care, and others.
  • Geographically, the global vitamin D testing market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is projected to capture a leading share of the global vitamin D testing market during the period of forecast.

Key Companies in the Vitamin D Testing Market

The report provides profiles of the leading players operating in the global diagnostic imaging services market. These include

  • Bio-Rad Laboratories, Inc.
  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific
  • DiaSys Diagnostic Systems GmbH
  • DiaSorin
  • bioMérieux
  • Siemens AG, Quest Diagnostics, and Danaher Corporation.

Vitamin D Testing Market – Scope of the Report

[257 Pages Report] Transparency Market Research’s latest study on the vitamin D testing market analyzes the growth of the market for the forecast period of 2019-2027. This report studies and evaluates the global market landscape, and provides a detailed outlook on the evolution of the vitamin D testing market, enabling readers to make important decisions in tandem to their businesses, based on the wealth of information in the report. The vitamin D testing market study considers 2018 as the base year, with everything before that as historical data and everything after as forecast.

The report provides data and insights on the vitamin D testing market, and also tracks the developments made by market players, along with a competitive landscape analysis of the same. The report also provides information on the drivers, indicators, restraints, opportunities, and threats to stakeholders in the vitamin D testing market landscape. Presented with a clear approach, this report on the vitamin D testing market gives readers an in-depth understanding of the market.

The report starts with an executive summary of the vitamin D testing market, followed by a complete analysis on tests, techniques, patients, indications, end users, and regions, along with insights on how the market is set to grow.

The study also discusses the major trends and impact of various factors on the vitamin D testing market, along with their influence on the growth of the market. The study also offers Porter’s Five Point Analysis, regulatory landscape, value chain analysis, and a SWOT analysis of the vitamin D testing market.

Key Questions Answered on the Vitamin D Testing Market

  • Which region is likely to be the most lucrative in the vitamin D testing market?
  • What are the drivers and restraints of the vitamin D testing market?
  • What are the opportunities that will present themselves to players in the radioimmunoassay technique in the vitamin D testing landscape?
  • How will the vitamin D testing market evolve during the forecast period?
  • Which test is likely to contribute to the maximum share of the vitamin D testing market?
  • What are the essential strategies incorporated by key stakeholders in the vitamin D testing market?

Vitamin D Testing Market: Research Methodology

This TMR report on the vitamin D testing market is based on a complete and exhaustive analysis of the market, backed by both, primary and secondary sources. The competitive framework of the vitamin D testing market is supported by a judgment of various elements that influence the market on a granular level. By thoroughly evaluating the historical data and current trends of the vitamin D testing market, analysts have arrived at estimated figures to calculate the projections for the market.

This report on the vitamin D testing market uses a data triangulation method, with a bottom-up approach to calculate important market numbers, and a top- down approach to validate them. Detailed evaluation of the vitamin D testing market is based on careful investigation of all the lucrative avenues, opportunities, and paths related to this market. Analysts’ conclusions on the growth and evolution of the vitamin D testing market are based on carefully-verified primary and secondary sources.

Vitamin D Testing Market: Segmentation

This report on the vitamin D testing market provides information on the basis of test, technique, patient, indication, end user, and region.

Test

25-Hydroxy D Vitamin

1,25-Dihydroxy D Vitamin

Technique

Radioimmunoassay

ELISA

HPLC

LC-MS

Others

Patient

Adult

Pediatric

Indication

Osteoporosis

Rickets

Thyroid Disorders

Malabsorption

Vitamin D Deficiency

Others

End User

Hospitals

Diagnostic Laboratories

Home Care

Point of Care

Others

Region

North America

Europe

Asia Pacific

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights 

2. Assumptions and Acronyms

3. Research Methodology

4. Executive Summary

5. Market Overview

    5.1. Definition

    5.2. Market Dynamics

        5.2.1. Drivers

            5.2.1.1. Vitamin D deficiency Epidemic

            5.2.1.2. Rising number of Vitamin D tests

            5.2.1.3. Rising prevalence of chronic diseases

            5.2.1.4. Increasing geriatric population leading to rise in target population

            5.2.1.5. Increasing need for vitamin D tests during pregnancy

        5.2.2. Restraints

            5.2.2.1. Low levels of awareness 

            5.2.2.2. Unnecessary screening for Vitamin D

        5.2.3. Opportunities

            5.2.3.1. Strategic partnerships for the distribution of test kits

            5.2.3.2. Untapped markets in emerging economies

        5.2.4. Global Vitamin D Testing Market Revenues (US$ Mn) Forecast, 2017–2027

        5.2.5. Global Vitamin D Testing Market Outlook

        5.2.6. Vitamin D Tests - Product Life Cycle

        5.2.7. Key Industry Developments

        5.2.8. Vitamin D Deficiency Prevalence

        5.2.9. Healthcare Industry Overview 

6. Global Vitamin D Testing Market Analysis, by Test

    6.1. Introduction

    6.2. Market Value Share Analysis, by Test 

    6.3. Market Value Forecast, by Test, 2017–2027

        6.3.1. 25-Hydroxy D Vitamin

        6.3.2. 1,25-Dihydroxy D Vitamin

    6.4. Market Attractiveness, by Test

7. Global Vitamin D Testing Market Analysis, by Technique

    7.1. Introduction

    7.2. Market Value Share Analysis, by Technique

    7.3. Market Value Forecast, by Technique, 2017–2027

        7.3.1. Radioimmunoassay

        7.3.2. ELISA

        7.3.3. HPLC

        7.3.4. LC-MS

        7.3.5. Others

    7.4. Market Attractiveness, by Technique

8. Global Vitamin D Testing Market Analysis, by Indication

    8.1. Introduction

    8.2. Market Value Share Analysis, by Indication

    8.3. Market Value Forecast, by Indication, 2017–2027

        8.3.1. Osteoporosis

        8.3.2. Rickets

        8.3.3. Thyroid Disorders

        8.3.4. Malabsorption

        8.3.5. Vitamin D Deficiency

        8.3.6. Others

    8.4. Market Attractiveness, by Indication

9. Global Vitamin D Testing Market Analysis, by Patient

    9.1. Introduction

    9.2. Market Value Share Analysis, by Patient

    9.3. Market Value Forecast, by Patient, 2017–2027

        9.3.1. Adult

        9.3.2. Pediatric

    9.4. Market Attractiveness, by Patient

10. Global Vitamin D Testing Market Analysis, by End User

    10.1. Introduction

    10.2. Market Value Share Analysis, by End User

    10.3. Market Value Forecast, by End User, 2017–2027

        10.3.1. Hospitals

        10.3.2. Diagnostic Laboratories

        10.3.3. Home Care

        10.3.4. Point-of-care

        10.3.5. Others

    10.4. Market Attractiveness, by End User

11. Global Vitamin D Testing Market Analysis, by Region

    11.1. Regional Outlook

    11.2. Global Scenario

    11.3. Introduction

    11.4. Market Value Share Analysis, by Region

        11.4.1. North America

        11.4.2. Europe

        11.4.3. Latin America

        11.4.4. Asia Pacific 

        11.4.5. Middle East & Africa

    11.5. Market Attractiveness Analysis, by Region

12. North America Vitamin D Testing Market Analysis

    12.1. Key Findings

    12.2. Market Value Forecast, by Country, 2017–2027

        12.2.1. U.S.

        12.2.2. Canada

    12.3. Market Value Forecast, by Test, 2017–2027

        12.3.1. 25-Hydroxy D Vitamin

        12.3.2. 1,25-Dihydroxy D Vitamin

    12.4. Market Value Forecast, by Technique, 2017–2027

        12.4.1. Radioimmunoassay

        12.4.2. ELISA

        12.4.3. HPLC

        12.4.4. LC-MS

        12.4.5. Others

    12.5. Market Value Forecast, by Indication, 2017–2027

        12.5.1. Osteoporosis

        12.5.2. Rickets

        12.5.3. Thyroid Disorders

        12.5.4. Malabsorption

        12.5.5. Vitamin D Deficiency

        12.5.6. Others

    12.6. Market Value Forecast, by Patient, 2017–2027

        12.6.1. Adult

        12.6.2. Pediatric

    12.7. Market Value Forecast, by End User, 2017–2027

        12.7.1. Hospitals

        12.7.2. Diagnostic Laboratories

        12.7.3. Home Care

        12.7.4. Point-of-care

        12.7.5. Others

    12.8. Market Attractiveness Analysis

        12.8.1. By Test

        12.8.2. By Technique

        12.8.3. By Indication

        12.8.4. By Patient

        12.8.5. By End User

        12.8.6. By Country

13. Europe Vitamin D Testing Market Analysis

    13.1. Key Findings

    13.2. Market Value Forecast, by Country/Sub-region, 2017–2027

        13.2.1. U.K.

        13.2.2. Germany

        13.2.3. France

        13.2.4. Italy

        13.2.5. Spain

        13.2.6. Rest of Europe

    13.3. Market Value Forecast, by Test, 2017–2027

        13.3.1. 25-Hydroxy D Vitamin

        13.3.2. 1,25-Dihydroxy D Vitamin

    13.4. Market Value Forecast, by Technique, 2017–2027

        13.4.1. Radioimmunoassay

        13.4.2. ELISA

        13.4.3. HPLC

        13.4.4. LC-MS

        13.4.5. Others

    13.5. Market Value Forecast, by Indication, 2017–2027

        13.5.1. Osteoporosis

        13.5.2. Rickets

        13.5.3. Thyroid Disorders

        13.5.4. Malabsorption

        13.5.5. Vitamin D Deficiency

        13.5.6. Others

    13.6. Market Value Forecast, by Patient, 2017–2027

        13.6.1. Adult

        13.6.2. Pediatric

    13.7. Market Value Forecast, by End User, 2017–2027

        13.7.1. Hospitals

        13.7.2. Diagnostic Laboratories

        13.7.3. Home Care

        13.7.4. Point-of-care

        13.7.5. Others

    13.8. Market Attractiveness Analysis

        13.8.1. By Test

        13.8.2. By Technique

        13.8.3. By Indication

        13.8.4. By Patient

        13.8.5. By End User

        13.8.6. By Country/Sub-region

14. Asia Pacific Vitamin D Testing Market Analysis

    14.1. Key Findings

    14.2. Market Value Forecast, by Country, 2017–2027

        14.2.1. China

        14.2.2. India

        14.2.3. Japan

        14.2.4. Australia

        14.2.5. Rest of Asia Pacific

    14.3. Market Value Forecast, by Test, 2017–2027

        14.3.1. 25-Hydroxy D Vitamin

        14.3.2. 1,25-Dihydroxy D Vitamin

    14.4. Market Value Forecast, by Technique, 2017–2027

        14.4.1. Radioimmunoassay

        14.4.2. ELISA

        14.4.3. HPLC

        14.4.4. LC-MS

        14.4.5. Others

    14.5. Market Value Forecast, by Indication, 2017–2027

        14.5.1. Osteoporosis

        14.5.2. Rickets

        14.5.3. Thyroid Disorders

        14.5.4. Malabsorption

        14.5.5. Vitamin D Deficiency

        14.5.6. Others

    14.6. Market Value Forecast, by Patient, 2017–2027

        14.6.1. Adult

        14.6.2. Pediatric

    14.7. Market Value Forecast, by End User, 2017–2027

        14.7.1. Hospitals

        14.7.2. Diagnostic Laboratories

        14.7.3. Home Care

        14.7.4. Point-of-care

        14.7.5. Others

    14.8. Market Attractiveness Analysis

        14.8.1. By Test

        14.8.2. By Technique

        14.8.3. By Indication

        14.8.4. By Patient

        14.8.5. By End User

        14.8.6. By Country/Sub-region

15. Latin America Vitamin D Testing Market Analysis

    15.1. Key Findings

    15.2. Market Value Forecast, by Country/Sub-region, 2017–2027

        15.2.1. Brazil

        15.2.2. Mexico

        15.2.3. Rest of Latin America

    15.3. Market Value Forecast, by Test, 2017–2027

        15.3.1. 25-Hydroxy D Vitamin

        15.3.2. 1,25-Dihydroxy D Vitamin

    15.4. Market Value Forecast, by Technique, 2017–2027

        15.4.1. Radioimmunoassay

        15.4.2. ELISA

        15.4.3. HPLC

        15.4.4. LC-MS

        15.4.5. Others

    15.5. Market Value Forecast, by Indication, 2017–2027

        15.5.1. Osteoporosis

        15.5.2. Rickets

        15.5.3. Thyroid Disorders

        15.5.4. Malabsorption

        15.5.5. Vitamin D Deficiency

        15.5.6. Others

    15.6. Market Value Forecast, by Patient, 2017–2027

        15.6.1. Adult

        15.6.2. Pediatric

    15.7. Market Value Forecast, by End User, 2017–2027

        15.7.1. Hospitals

        15.7.2. Diagnostic Laboratories

        15.7.3. Home Care

        15.7.4. Point-of-care

        15.7.5. Others

    15.8. Market Attractiveness Analysis

        15.8.1. By Test

        15.8.2. By Technique

        15.8.3. By Indication

        15.8.4. By Patient

        15.8.5. By End User

        15.8.6. By Country/Sub-region

16. Middle East & Africa Vitamin D Testing Market Analysis

    16.1. Key Findings

    16.2. Market Value Forecast, by Country/Sub-region, 2017–2027

        16.2.1. GCC Countries 

        16.2.2. Israel 

        16.2.3. South Africa

        16.2.4. Rest of Middle East & Africa

    16.3. Market Value Forecast, by Test, 2017–2027

        16.3.1. 25-Hydroxy D Vitamin

        16.3.2. 1,25-Dihydroxy D Vitamin

    16.4. Market Value Forecast, by Technique, 2017–2027

        16.4.1. Radioimmunoassay

        16.4.2. ELISA

        16.4.3. HPLC

        16.4.4. LC-MS

        16.4.5. Others

    16.5. Market Value Forecast, by Indication, 2017–2027

        16.5.1. Osteoporosis

        16.5.2. Rickets

        16.5.3. Thyroid Disorders

        16.5.4. Malabsorption

        16.5.5. Vitamin D Deficiency

        16.5.6. Others

    16.6. Market Value Forecast, by Patient, 2017–2027

        16.6.1. Adult

        16.6.2. Pediatric

    16.7. Market Value Forecast, by End User, 2017–2027

        16.7.1. Hospitals

        16.7.2. Diagnostic Laboratories

        16.7.3. Home Care

        16.7.4. Point-of-care

        16.7.5. Others

    16.8. Market Attractiveness Analysis

        16.8.1. By Test

        16.8.2. By Technique

        16.8.3. By Indication

        16.8.4. By Patient

        16.8.5. By End User

        16.8.6. By Country/Sub-region

17. Company Profiles

    17.1. DiaSorin S.p.A. 

        17.1.1. Company Overview (Headquarters, Business Segments, Employee Strength)

        17.1.2. Financial Overview

        17.1.3. SWOT Analysis

        17.1.4. Strategic Overview

    17.2. DiaSys Diagnostic Systems GmbH 

        17.2.1. Company Overview (Headquarters, Business Segments, Employee Strength)

        17.2.2. Financial Overview

        17.2.3. SWOT Analysis

        17.2.4. Strategic Overview

    17.3. bioMérieux SA 

        17.3.1. Company Overview (Headquarters, Business Segments, Employee Strength)

        17.3.2. Financial Overview

        17.3.3. SWOT Analysis

        17.3.4. Strategic Overview

    17.4. Bio-Rad Laboratories 

        17.4.1. Company Overview (Headquarters, Business Segments, Employee Strength)

        17.4.2. Financial Overview

        17.4.3. SWOT Analysis

        17.4.4. Strategic Overview

    17.5. Abbott Laboratories 

        17.5.1. Company Overview (Headquarters, Business Segments, Employee Strength)

        17.5.2. Financial Overview

        17.5.3. SWOT Analysis

        17.5.4. Strategic Overview

    17.6. Siemens Healthineers 

        17.6.1. Company Overview (Headquarters, Business Segments, Employee Strength)

        17.6.2. Financial Overview

        17.6.3. SWOT Analysis

        17.6.4. Strategic Overview

    17.7. F. Hoffmann-La Roche Ltd 

        17.7.1. Company Overview (Headquarters, Business Segments, Employee Strength)

        17.7.2. Financial Overview

        17.7.3. SWOT Analysis

        17.7.4. Strategic Overview

    17.8. Thermo Fisher Scientific, Inc. 

        17.8.1. Company Overview (Headquarters, Business Segments, Employee Strength)

        17.8.2. Financial Overview

        17.8.3. SWOT Analysis

        17.8.4. Strategic Overview

    17.9. Quest Diagnostics Incorporated 

        17.9.1. Company Overview (Headquarters, Business Segments, Employee Strength)

        17.9.2. Financial Overview

        17.9.3. SWOT Analysis

        17.9.4. Strategic Overview

    17.10. Danaher Corporation 

        17.10.1. Company Overview (Headquarters, Business Segments, Employee Strength)

        17.10.2. Financial Overview

        17.10.3. SWOT Analysis

        17.10.4. Strategic Overview

List of Tables

Table 01: Global Vitamin D Testing Market Value (US$ Mn) Forecast, by Test, 2017–2027
Table 02: Global Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 03: Global Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 04: Global Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient, 2017–2027
Table 05: Global Vitamin D Testing Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 06: Global Vitamin D Testing Market Size (US$ Mn) Forecast, by Region, 2017–2027
Table 07: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 08: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by Test, 2017–2027
Table 09: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 10: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient, 2017–2027
Table 11: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 12: North America Vitamin D Testing Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 13: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 14: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by Test, 2017–2027
Table 15: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 16: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient, 2017–2027
Table 17: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 18: Europe Vitamin D Testing Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 19: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 20: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by Test, 2017–2027
Table 21: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 22: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient, 2017–2027
Table 23: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 24: Asia Pacific Vitamin D Testing Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 25: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 26: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by Test, 2017–2027
Table 27: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 28: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient, 2017–2027
Table 29: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 30: Latin America Vitamin D Testing Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 31: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 32: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by Test, 2017–2027
Table 33: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by Technique, 2017–2027
Table 34: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by Patient, 2017–2027
Table 35: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 36: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) Forecast, by End User, 2017–2027

List of Figures

Figure 01: Global Vitamin D Testing Market Snapshot
Figure 02: Global Vitamin D Testing Market Value (US$ Mn) and Distribution (%), by Region, 2019 and 2027
Figure 03: Global Vitamin D Testing Market Value (US$ Mn) Forecast, 2017–2027
Figure 04: Global Vitamin D Testing Market Value Share (%), by Test, 2018
Figure 05: Global Vitamin D Testing Market Value Share (%), by Technique, 2018
Figure 06: Global Vitamin D Testing Market Value Share (%), by Indication, 2018
Figure 07: Global Vitamin D Testing Market Value Share (%), by Patient, 2018
Figure 08: Global Vitamin D Testing Market Value Share (%), by End User, 2018
Figure 09: Global Vitamin D Testing Market Value Share (%), by Region, 2018
Figure 10: Vitamin D Tests - Product Life Cycle
Figure 11: Vitamin D Testing Market - Key Industry Developments
Figure 12: Vitamin D Deficiency - Prevalence
Figure 13: Global Vitamin D Testing Market Value Share Analysis, by Test, 2018 and 2027
Figure 14: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by 25-Hydroxy D Vitamin, 2017–2027
Figure 15: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by 1,25-ihydroxy D Vitamin, 2017–2027
Figure 16: Global Vitamin D Testing Market Attractiveness, by Test, 2019?2027
Figure 17: Key Trends - Global Vitamin D Testing Market, by Test
Figure 18: Global Vitamin D Testing Market Value Share Analysis, by Technique, 2018 and 2027
Figure 19: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Radioimmunoassay, 2017–2027
Figure 20: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by ELISA, 2017–2027
Figure 21: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by HPLC, 2017–2027
Figure 22: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by LC-MS, 2017–2027
Figure 23: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027
Figure 24: Global Vitamin D Testing Market Attractiveness, by Technique, 2019?2027
Figure 25: Key Trends - Global Vitamin D Testing Market, by Technique
Figure 26: Global Vitamin D Testing Market Value Share Analysis, by Indication, 2018 and 2027
Figure 27: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Osteoporosis, 2017–2027
Figure 28: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Rickets, 2017–2027
Figure 29: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Thyroid 
Disorders, 2017–2027
Figure 30: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Malabsorption, 2017–2027
Figure 31: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Vitamin D Deficiency, 2017–2027
Figure 32: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027
Figure 33: Global Vitamin D Testing Market Attractiveness, by Indication, 2019?2027
Figure 34: Key Trends - Global Vitamin D Testing Market, by Indication
Figure 35: Global Vitamin D Testing Market Value Share Analysis, by Patient, 2018 and 2027
Figure 36: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Adult, 2017–2027
Figure 37: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Pediatric, 2017–2027
Figure 38: Global Vitamin D Testing Market Attractiveness, by Patient, 2019?2027
Figure 39: Key Trends - Global Vitamin D Testing Market, by Patient
Figure 40: Global Vitamin D Testing Market Value Share Analysis, by End User, 2018 and 2027
Figure 41: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2017–2027
Figure 42: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Laboratories, 2017–2027
Figure 43: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Home Care, 2017–2027
Figure 44: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Point-of-care, 2017–2027
Figure 45: Global Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017–2027
Figure 46: Global Vitamin D Testing Market Attractiveness, by End User, 2019?2027
Figure 47: Key Trends - Global Vitamin D Testing Market, by End User
Figure 48: Vitamin D Testing Market: Regional Outlook
Figure 49: Global Vitamin D Testing Market Value (US$ Mn) Forecast, 2017–2027
Figure 50: Global Vitamin D Testing Market Value Share Analysis, by Region, 2018 and 2027
Figure 51: Global Vitamin D Testing Market Attractiveness, by Region, 2019-2027
Figure 52: North America Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 53: North America Vitamin D Testing Market Attractiveness Analysis, by Country, 2019–2027
Figure 54: North America Vitamin D Testing Market Value Share Analysis, by Country, 2018 and 2027
Figure 55: North America Vitamin D Testing Market Value Share Analysis, by Test, 2018 and 2027
Figure 56: North America Vitamin D Testing Market Value Share Analysis, by Technique, 2018 and 2027
Figure 57: North America Vitamin D Testing Market Value Share Analysis, by Patient, 2018 and 2027
Figure 58: North America Vitamin D Testing Market Value Share Analysis, by Indication, 2018 and 2027
Figure 59: North America Vitamin D Testing Market Value Share Analysis, by End User, 2018 and 2027
Figure 60: North America Vitamin D Testing Market Attractiveness, by Test, 2019?2027
Figure 61: North America Vitamin D Testing Market Attractiveness, by Technique, 2019?2027
Figure 62: North America Vitamin D Testing Market Attractiveness, by Patient, 2019?2027
Figure 63: North America Vitamin D Testing Market Attractiveness, by Indication, 2019?2027
Figure 64: North America Vitamin D Testing Market Attractiveness, by End User, 2019?2027
Figure 65: Europe Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 66: Europe Vitamin D Testing Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 67: Europe Vitamin D Testing Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 68: Europe Vitamin D Testing Market Value Share Analysis, by Test, 2018 and 2027
Figure 69: Europe Vitamin D Testing Market Value Share Analysis, by Technique, 2018 and 2027
Figure 70: Europe Vitamin D Testing Market Value Share Analysis, by Patient, 2018 and 2027
Figure 71: Europe Vitamin D Testing Market Value Share Analysis, by Indication, 2018 and 2027
Figure 72: Europe Vitamin D Testing Market Value Share Analysis, by End User, 2018 and 2027
Figure 73: Europe Vitamin D Testing Market Attractiveness, by Test, 2019?2027
Figure 74: Europe Vitamin D Testing Market Attractiveness, by Technique, 2019?2027
Figure 75: Europe Vitamin D Testing Market Attractiveness, by Patient, 2019?2027
Figure 76: Europe Vitamin D Testing Market Attractiveness, by Indication, 2019?2027
Figure 77: Europe Vitamin D Testing Market Attractiveness, by End User, 2019?2027
Figure 78: Asia Pacific Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 79: Asia Pacific Vitamin D Testing Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 80: Asia Pacific Vitamin D Testing Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 81: Asia Pacific Vitamin D Testing Market Value Share Analysis, by Test, 2018 and 2027
Figure 82: Asia Pacific Vitamin D Testing Market Value Share Analysis, by Technique, 2018 and 2027
Figure 83: Asia Pacific Vitamin D Testing Market Value Share Analysis, by Patient, 2018 and 2027
Figure 84: Asia Pacific Vitamin D Testing Market Value Share Analysis, by Indication, 2018 and 2027
Figure 85: Asia Pacific Vitamin D Testing Market Value Share Analysis, by End User, 2018 and 2027
Figure 86: Asia Pacific Vitamin D Testing Market Attractiveness, by Test, 2019?2027
Figure 87: Asia Pacific Vitamin D Testing Market Attractiveness, by Technique, 2019?2027
Figure 88: Asia Pacific Vitamin D Testing Market Attractiveness, by Patient, 2019?2027
Figure 89: Asia Pacific Vitamin D Testing Market Attractiveness, by Indication, 2019?2027
Figure 90: Asia Pacific Vitamin D Testing Market Attractiveness, by End User, 2019?2027
Figure 91: Latin America Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 92: Latin America Vitamin D Testing Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 93: Latin America Vitamin D Testing Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 94: Latin America Vitamin D Testing Market Value Share Analysis, by Test, 2018 and 2027
Figure 95: Latin America Vitamin D Testing Market Value Share Analysis, by Technique, 2018 and 2027
Figure 96: Latin America Vitamin D Testing Market Value Share Analysis, by Patient, 2018 and 2027
Figure 97: Latin America Vitamin D Testing Market Value Share Analysis, by Indication, 2018 and 2027
Figure 98: Latin America Vitamin D Testing Market Value Share Analysis, by End User, 2018 and 2027
Figure 99: Latin America Vitamin D Testing Market Attractiveness, by Test, 2019?2027
Figure 100: Latin America Vitamin D Testing Market Attractiveness, by Technique, 2019?2027
Figure 101: Latin America Vitamin D Testing Market Attractiveness, by Patient, 2019?2027
Figure 102: Latin America Vitamin D Testing Market Attractiveness, by Indication, 2019?2027
Figure 103: Latin America Vitamin D Testing Market Attractiveness, by End User, 2019?2027
Figure 104: Middle East & Africa Vitamin D Testing Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027
Figure 105: Middle East & Africa Vitamin D Testing Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 106: Middle East & Africa Vitamin D Testing Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 107: Middle East & Africa Vitamin D Testing Market Value Share Analysis, by Test, 2018 and 2027
Figure 108: Middle East & Africa Vitamin D Testing Market Value Share Analysis, by Technique, 2018 and 2027
Figure 109: Middle East & Africa Vitamin D Testing Market Value Share Analysis, by Patient, 2018 and 2027
Figure 110: Middle East & Africa Vitamin D Testing Market Value Share Analysis, by Indication, 2018 and 2027
Figure 111: Middle East & Africa Vitamin D Testing Market Value Share Analysis, by End User, 2018 and 2027
Figure 112: Middle East & Africa Vitamin D Testing Market Attractiveness, by Test, 2019?2027
Figure 113: Middle East & Africa Vitamin D Testing Market Attractiveness, by Technique, 2019?2027
Figure 114: Middle East & Africa Vitamin D Testing Market Attractiveness, by Patient, 2019?2027
Figure 115: Middle East & Africa Vitamin D Testing Market Attractiveness, by Indication, 2019?2027
Figure 116: Middle East & Africa Vitamin D Testing Market Attractiveness, by End User, 2019?2027

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Vitamin D Testing Market